2030 年植入式医疗器械市场报告(按细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPMD00002673
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 207
Buy Now

Implantable Medical Devices Market Share Report | Growth Outlook 2022 to 2030

Buy Now

 

植入式医疗器械市场预计将从 2022 年的 801.56 亿美元增长,到 2030 年预计将达到 1384.7435 亿美元;预计 2022 年至 2030 年的复合年增长率为 7.1%。

 

市场洞察和分析师观点:

植入式医疗设备是一种完全或部分植入人体的设备。这些医疗设备通常由医生在手术过程中植入。与外科医疗设备相比,植入式医疗设备在手术后仍留在体内。推动植入式医疗设备市场增长的关键因素包括植入式医疗设备的应用领域不断扩大以及脊髓损伤病例不断增加。

 

增长动力和限制因素:

根据世界卫生组织的数据,2022 年,美国记录了 5000 万例癫痫病例、10 亿例偏头痛病例和 40 万例脊髓损伤病例。脊髓刺激是治疗慢性背痛最受欢迎的技术之一,这主要是因为脊髓神经具有控制疼痛感觉的解剖和功能能力。过去十年来,脊髓损伤的发病率迅速上升。美国国家脊髓损伤统计中心 (NSCISC) 2021 年情况说明书指出,脊髓损伤的年发病率为每百万 60 例。根据 2022 年 4 月发表的文章《创伤性脊髓损伤的流行病学:一项基于人群的大型研究》,2021 年创伤性脊髓损伤的总体年龄-性别标准化发病率为每 100 万人口 26.5 例,并且发病率与男女年龄直接相关。根据同一来源,在老年人口(65 岁及以上)中,男性和女性的发病率分别为每 100 万 59.2 例和 23.3 例。脊髓刺激器广泛用于治疗脊柱手术后的疼痛。根据题为《脊髓损伤事实和统计》的报告,2021 年,每年约有 17,700 名美国人遭受脊髓损伤,其中约 78% 是平均年龄为 43 岁的男性。因此,老年人口和成年人脊髓损伤的高发病率刺激了对植入式神经刺激装置的需求,从而促进了市场增长。

然而,使用植入式医疗设备可以挽救生命,因为这些设备可以减轻疼痛和不适,同时恢复活动能力并改善患者的健康状况。然而,矫形植入手术也存在一些并发症,例如骨折固定、设备故障和关节置换并发症,包括关节、肩关节、肘关节、髋关节和膝关节脱位。此外,植入物被身体排斥、关节植入物感染、血栓、关节植入物松动和神经血管损伤是与矫形植入物相关的并发症。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

植入式医疗器械市场:

植入式医疗器械市场
  • Implantable Medical Devices Market
    复合年增长率(2022 - 2030 年)
    7.1%
  • 2022 年市场规模
    801.6 亿美元
  • 2030 年市场规模
    1,384.7 亿美元

市场动态

增长动力
  • 脊髓损伤病例不断增加
  • 植入式医疗器械的应用领域不断扩大
未来的趋势
  • 3D 打印技术的使用日益广泛
机会
  • 智能植入物的采用和批准日益增多

关键人物;主力;重要一员

  •  
  • 雅培实验室
  • 波士顿科学公司
  • 登士柏西诺德公司
  • 强生公司
  • 美敦力公司
  • 施特劳曼研究所
  • 史密斯和侄子公司
  • BIOTRONIK SE & Co KG
  • 利瓦诺瓦公司

区域概况

Implantable Medical Devices Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Implantable Medical Devices Market自然类型
  • 有源植入和无源植入
Implantable Medical Devices Market产品类别
  • 诊断和治疗
Implantable Medical Devices Market材料种类
  • 金属
  • 陶瓷制品
  • 聚合物
Implantable Medical Devices Market应用
  • 骨科植入物
  • 心血管植入物
  • 乳房植入物
  • 大脑植入物
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

此外,还有各种用于静脉和鞘内给药以及处理与癌症治疗相关的各种合并症和并发症的设备。其中一些设备包括中央静脉通路设备 (CVAD)、心脏植入式电子设备 (CIED)、Ommaya 储液器、外部脑室引流管 (EVD)、乳房植入物加组织扩张器 (TE) 以及经皮肾造瘘管 (PCNT) 等。

与这些装置相关的感染很常见,这会导致医疗费用增加,并导致患者在短期和长期肿瘤管理中出现并发症。这通常会导致进一步的癌症治疗被推迟,直到感染得到解决。治疗这些感染并更换或移除装置通常是必要的。然而,移除植入物可能很困难,在某些情况下,由于患者的潜在血小板减少症、合并症、缺乏血管通路、免疫抑制和先前的手术干预,移除植入物甚至是禁止的。此外,治疗这些感染的报销额很低。因此,术后并发症阻碍了市场的增长。

 

报告细分和范围:

全球植入式医疗器械市场根据性质类型、产品类型、材料类型、应用和最终用户进行分类。根据性质类型,植入式医疗器械市场分为主动植入物和被动植入物。根据产品类型,植入式医疗器械分为诊断和治疗。根据材料类型,市场细分为金属、陶瓷和聚合物。在应用方面,植入式医疗器械市场细分为心血管植入物、骨科植入物、心血管植入物、乳房植入物、假肢植入物、脑植入物和其他。在最终用户方面,市场分为医院、专科诊所、ASC 和其他。根据地理位置,植入式医疗器械市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

 

节段分析:

植入式医疗器械市场按性质分为主动植入物和被动植入物。被动植入物部分在 2022 年占据了较大的市场份额。然而,主动植入物部分预计在 2022-2030 年期间的复合年增长率会更高。被动植入物没有任何电子或磁性元件,也不需要任何外部电源即可运行。被动植入物的一些例子包括导管、电导线、动脉瘤夹、支架、外固定装置、髋关节假体和下腔静脉 (IVC) 过滤器。MRI 可能通过加热、旋转、位移和磁化等机制影响被动植入物。

植入式医疗器械市场按产品类型分为诊断和治疗两大类。治疗类产品在 2022 年占据了较大的市场份额;此外,预计同一类产品在 2022-2030 年的复合年增长率将更高。植入式医疗器械被置入体内以输送药物并支持特定器官的功能。植入式医疗器械通常用于治疗心脏病。此外,各种类型的假体(如骨科和牙科植入物)用于替换受损的身体部位。

植入式医疗器械市场按材料类型细分为金属、陶瓷和聚合物。金属部分在 2022 年占据最大市场份额,而聚合物部分预计在 2022-2030 年期间的复合年增长率最高。金属植入物广泛用于牙科、心脏装置、整形外科和妇科手术。例如,钴铬钼合金用于骨科植入物和假牙框架。同样,钴及其合金用于除颤器的制造。此外,乙烯-醋酸乙烯酯共聚物 (EVA)、硅树脂、聚醚醚酮 (PEEK) 聚合物和超高分子量聚乙烯 (UHMW-PE) 等聚合物因其易于制造、灵活性和生物相容性而被广泛用于制造医疗植入物。

植入式医疗器械市场按应用细分为牙科植入物、骨科植入物、心血管植入物、乳房植入物、脑植入物等。骨科植入物细分市场在 2022 年占据最大市场份额,预计同一细分市场在 2022-2030 年期间的复合年增长率最高。骨科植入物用于替换因畸形或损伤而导致的软骨、骨骼或关节。大多数骨科植入物由钛合金和不锈钢制成,其中一些甚至可能覆盖有塑料。塑料衬里用作人造软骨,而金属结构为植入物提供必要的强度。通常,植入物被固定到位,支撑骨骼在其中生长以提高强度。钛等金属合金是用作假肢的骨科植入物中最常用的材料之一,包括膝关节和髋关节置换术。金属合金也用于骨板和骨螺钉。陶瓷和聚合物是用于合成骨科植入物的其他材料之一。

植入式医疗器械市场按最终用户细分为医院、专科诊所、ASC 和其他。2022 年,医院部门占据最大市场份额,预计该部门在 2022-2030 年期间的复合年增长率最高。  

 

区域分析:

根据地域划分,全球植入式医疗器械市场分为五个主要区域:北美、欧洲、亚太、南美和中美以及中东和非洲。2022 年,北美占据全球植入式医疗器械市场规模的最大份额。预计亚太地区在 2022-2030 年期间的复合年增长率最高。

据估计,美国将在 2022-2030 年期间占据最大的植入式医疗器械市场份额。帕金森病等神经系统疾病发病率上升、人们对神经系统疾病的认识不断提高以及对开发颅内刺激器的投资不断增加是推动美国整体植入式设备市场发展的主要因素。多巴胺读数低和其他遗传因素是导致帕金森病的主要原因之一。根据阿尔茨海默病协会发表的一项题为“2022 年阿尔茨海默病事实和数据”的研究,2022 年约有 650 万 65 岁及以上的美国人被诊断患有阿尔茨海默病。预计到 2060 年,这一数字将达到 1380 万。根据脑动脉瘤基金会 2019 年发布的数据,在美国,约有 600 万人患有未破裂的脑动脉瘤。此外,每年的破裂率接近每 100,000 人 8-10 人;美国约有 30,000 人患有脑动脉瘤破裂。据观察,深部脑刺激 (DBS) 设备可有效控制与帕金森病相关的震颤。

根据帕金森基金会的数据,美国约有 100 万人患有帕金森病,预计到 2030 年将增加到 120 万人。技术进步和新产品的推出推动了植入式医疗器械市场的发展。2020 年 1 月,雅培的 Infinity DBS 系统获得了美国食品药品监督管理局 (FDA) 的批准,可用于治疗帕金森病。该系统可以针对大脑的特定区域进行有针对性的治疗,该区域称为内苍白球 (GPi),与帕金森病的症状有关。因此,神经系统疾病的日益流行和技术进步推动了美国植入式医疗器械市场的增长。

 

行业发展和未来机遇:

以下列出了全球植入式医疗器械市场的主要参与者采取的各种举措:

  1. 2023 年 8 月,美敦力公司 Inceptiv 闭环可充电脊髓刺激器 (SCS) 获得 CE(欧洲合格认证)标志认证。这是美敦力第一款提供闭环功能的 SCS 设备,该功能可感知每个人独特的生物信号,并根据需要随时调整刺激,使治疗与日常生活动作保持一致。
  2. 2023 年 5 月,BIOTRONIK 宣布其心律管理产品组合中新增了 Amvia Sky 和 ​​Amvia Edge。BIOTRONIK 的最新技术获得了 CE 标志——这是世界上首批获准用于左束支起搏的起搏器和 CRT-P。Amvia Sky 和 ​​Amvia Edge 代表了尖端创新,并融合了最新的心脏病学趋势。
  3. 2023 年 3 月,登士柏西诺德推出了 DS OmniTaper 种植系统,这是 EV 种植体系列的最新成员。DS OmniTaper 种植系统是一种创新解决方案,它将登士柏西诺德 EV 种植体系列的成熟技术与提供效率和多功能性的新功能相结合。
  4. 2023 年 2 月,美敦力公司获得了 Aurora EV-ICD MRI SureScan(血管外植入式心脏复律除颤器)和 Epsila EV MRI SureScan 除颤导线的 CE(欧洲合格认证)标志,用于治疗可能导致心脏骤停的危险快速心律。Aurora EV-ICD 系统具有传统 ICD 的救生优势,同时避免了某些风险,因为其导线(细线)放置在心脏和静脉之外。
  5. 2023 年 1 月,雅培宣布美国食品药品监督管理局 (FDA) 批准其 Proclaim XR 脊髓刺激 (SCS) 系统用于治疗糖尿病引起的疼痛性糖尿病周围神经病变 (DPN),这是一种使人衰弱的糖尿病并发症。Proclaim XR SCS 系统可以为需要传统治疗方法(如口服药物)替代方案的 DPN 患者提供缓解。接受 Proclaim XR SCS 系统治疗的患者还将能够使用雅培的 NeuroSphere Virtual Clinic,这是一款联网护理应用程序,可让人们与医生沟通并远程接受治疗调整。

 

植入式医疗器械市场报告范围

报告属性细节
2022 年市场规模801.6亿美元
2030 年的市场规模1384.7亿美元
全球复合年增长率(2022 - 2030 年)7.1%
历史数据2020-2021
预测期2023-2030
涵盖的领域按性质类型
  • 有源植入和无源植入
按产品类型
  • 诊断和治疗
按材料类型
  • 金属
  • 陶瓷制品
  • 聚合物
按应用
  • 骨科植入物
  • 心血管植入物
  • 乳房植入物
  • 大脑植入物
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 雅培实验室
  • 波士顿科学公司
  • 登士柏西诺德公司
  • 强生公司
  • 美敦力公司
  • 施特劳曼研究所
  • 史密斯和侄子公司
  • BIOTRONIK SE & Co KG
  • 利瓦诺瓦公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

竞争格局和重点公司:

雅培实验室、波士顿科学公司、登士柏西诺德公司、强生公司、美敦力公司、斯特劳曼研究所、施乐辉公司、BIOTRONIK SE & Co KG、LivaNova Plc 和 MED-EL Elektromedizin Gerate GmbH 是植入式医疗器械市场的知名企业。这些公司专注于新技术、现有产品的改进和地域扩张,以满足全球日益增长的消费者需求,并扩大其专业产品组合的范围。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which application segment dominates the implantable medical devices market?

The implantable medical devices market, by application, is segmented into dental implants, orthopedic implants, cardiovascular implants, breast implants, brain implants, and others. The orthopedic implants segment held a largest market share in 2022 and same segment is anticipated to register a highest CAGR during the 2022-2030.

Which product type segment dominates the implantable medical devices market?

The implantable medical devices market, by product type, is segmented into diagnostic and treatment. The treatment segment held a larger market share in 2022 also the same segment is anticipated to register a higher CAGR during 2022-2030.

Which end user segment dominates the implantable medical devices market?

The implantable medical devices market, by end users, is segmented into hospitals, specialty clinics, ASCs, and others. The hospitals segment held largest market share in 2022 and same segment is anticipated to register a highest CAGR during the 2022-2030.

Which material type segment dominates the implantable medical devices market?

The implantable medical devices market, by material type, is segmented into metallic, ceramic, and polymers. The metallic segment held a largest market share in 2022 and polymers segment is anticipated to register a highest CAGR during 2022-2030.

Which nature type segment dominates the implantable medical devices market?

The implantable medical devices market, by nature type, is segmented into active implant and passive implant. The passive implant segment held a larger market share in 2022. However, active implant segment is anticipated to register a higher CAGR during 2022-2030.

What are the growth estimates for the implantable medical devices market till 2030?

The implantable medical devices market is expected to be valued at US$ 138,474.35 million in 2030.

What was the estimated implantable medical devices market size in 2022?

The implantable medical devices market was valued at US$ 80,156.00 million in 2022.

What factors drive the implantable medical devices market?

Factors such as growing areas of application of implantable medical devices and rising cases of spinal cord injury propel market growth.

What are implantable medical devices?

Implantable medical devices are the devices that are either completely or partially implanted into the body. These medical devices are often implanted during surgical procedures by physicians. Implantable medical devices, as compared to surgical medical devices, remain in the body after the surgery.

Who are the major players in the implantable medical devices market?

The implantable medical devices market majorly consists of the players, including Abbott Laboratories, Boston Scientific Corp, Dentsply Sirona Inc, Johnson & Johnson, Medtronic Plc, Institut Straumann AG, Smith & Nephew Plc, BIOTRONIK SE & Co KG, LivaNova Plc, and MED-EL Elektromedizin Gerate GmbH.

The List of Companies - Implantable Medical Devices Market

  1. Abbott Laboratories          
  2. Boston Scientific Corp      
  3. Dentsply Sirona Inc          
  4. Johnson & Johnson          
  5. Medtronic Plc       
  6. Institut Straumann AG      
  7. Smith & Nephew Plc         
  8. BIOTRONIK SE & Co KG             
  9. LivaNova Plc        
  10. MED-EL Elektromedizin Gerate Gesellschaft mbH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..